文献速递腹部介入MR

胆管弥散加权成像高信号预测ABO血型不合肝移植术后肝内胆道并发症

Bile duct diffusion-weighted image hyperintensity predicts intrahepatic biliary complications after ABO-incompatible liver transplantation.
PubMed 文献 · Eur Radiol · 2024-07-09

单中心回顾性研究分析56例ABO血型不合肝移植患者,术后住院期间行MRCP和DWI检查,胆管DWI高信号者肝内胆道并发症发生率更高(33.3% vs 5.6%,p=0.01),且弥漫型更多见(22.2% vs 2.8%,p=0.04),回归分析显示胆管DWI高信号是肝内胆道并发症的独立危险因素(OR 10.1)。结论认为术后胆管DWI高信号可作为预测ABO血型不合肝移植术后肝内胆道并发症的生物标志物。

要点

  • ABO血型不合肝移植术后胆管DWI高信号者肝内胆道并发症发生率33.3%,无高信号者5.6%(p=0.01)。
  • 胆管DWI高信号是肝内胆道并发症的独立危险因素(OR 10.1,95%CI 1.4, 71.2;p=0.02)。
  • 胆管DWI高信号者弥漫型肝内胆道并发症更常见(22.2% vs 2.8%,p=0.04)。

核心结论

  • 术后胆管DWI高信号可作为预测ABO血型不合肝移植术后肝内胆道并发症的生物标志物,并有助于识别可能从针对抗体介导排斥反应的额外管理中获益的候选者。

研究设计与样本

  • 单中心回顾性研究,纳入2021年3月至2023年1月接受ABO血型不合肝移植的56例患者,全部在术后住院期间接受MRCP和DWI检查,评估包括胆管DWI高信号在内的MRCP表现;疑似胆道感染或梗阻性黄疸者随访期间行ERCP或PTBD,胆管造影上的非吻合口胆道狭窄分类为肝内胆道并发症(分肝门周围型和弥漫型)。

诊断标准与关键数值

  • 55例参与者(中位年龄55岁,男性39例)中,中位随访15.9个月(范围5.6-31.1)内8例诊断为肝内胆道并发症;18例观察到胆管DWI高信号,其肝内胆道并发症发生率为6/18(33.3%),无DWI高信号者为2/36(5.6%)(p=0.01);弥漫型肝内胆道并发症在DWI高信号组为4/18(22.2%),无高信号组为1/36(2.8%)(p=0.04);回归分析显示胆管DWI高信号是肝内胆道并发症的独立危险因素(OR 10.1;95%CI 1.4, 71.2;p=0.02),也是弥漫型的独立危险因素(OR 15.3;95%CI 1.2, 187.8;p=0.03)。

临床应用与阅片要点

  • 术后早期DWI上胆管高信号与肝内胆道并发症风险增加相关,可作为识别需要强化管理以预防并发症的个体的额外方法;该标志物有助于识别可能从针对抗体介导排斥反应的额外管理中获益的候选者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We assessed the value of the diffusion-weighted image (DWI) for predicting intrahepatic biliary complications (IHBC) after ABO-incompatible liver transplantation (ABOi-LT), potentially leading to refractory cholangitis.

MATERIALS AND METHODS: In this retrospective study at a single center, 56 patients who underwent ABOi-LT from March 2021 to January 2023 were analyzed. All received magnetic resonance cholangiopancreatography (MRCP) and DWI during the postoperative hospitalization. MRCP findings, including bile duct DWI hyperintensity, were assessed. Participants suspected of having a biliary infection or obstructive jaundice underwent endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic biliary drainage (PTBD) during the follow-up. Non-anastomotic biliary strictures on cholangiography were classified as IHBC, as either perihilar or diffuse form. DWI hyperintensity was compared between groups with and without IHBC. Logistic regression analysis was performed to identify independent risk factors for IHBC.

RESULTS: Of the 55 participants (median age 55 years, 39 males), IHBC was diagnosed in eight patients over a median follow-up of 15.9 months (range 5.6-31.1). Bile duct DWI hyperintensity was observed in 18 patients. Those with DWI hyperintensity exhibited a higher IHBC incidence (6/18, 33.3% vs. 2/36, 5.6%; p = 0.01), and more frequently developed the diffuse type IHBC (4/18, 22.2% vs. 1/36, 2.8%; p = 0.04). Regression analysis indicated that bile duct DWI hyperintensity is an independent risk factor for IHBC (odds ratio (OR) 10.1; 95% confidence interval (CI) 1.4, 71.2; p = 0.02) and its diffuse form (OR 15.3; 95% CI 1.2, 187.8; p = 0.03).

CONCLUSION: Postoperative DWI hyperintensity of bile ducts can serve as a biomarker predicting IHBC after ABOi-LT.

CLINICAL RELEVANCE STATEMENT: Postoperative diffusion-weighted image hyperintensity of the bile duct can be used as a biomarker to predict intrahepatic biliary complications and aid in identifying candidates who may benefit from additional management for antibody-mediated rejection.

KEY POINTS: Intrahepatic biliary complications following ABO-incompatible liver transplantation can cause biliary stricture and biloma formation. Bile duct hyperintensity on early postoperative diffusion-weighted imaging was associated with increased intrahepatic biliary complication risk. This marker is an additional method for identifying individuals who require intensive management to prevent complications.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Gu K, Jeong WK, Cha DI, et al. Bile duct diffusion-weighted image hyperintensity predicts intrahepatic biliary complications after ABO-incompatible liver transplantation. Eur Radiol. 2024. PMID: 38981894. doi:10.1007/s00330-024-10914-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。